UCSF has hired two senior managers to strengthen the University’s research enterprise.
July 21, 2010
Larissa Podust, PhD, is working on a new drug for Chagas disease, a neglected scourge.
July 19, 2010
With innovation as the watchword, a biotech spinoff from the UCSF School of Pharmacy announced a $40 million Series A round of investment last week – hailed by an investor as “one of the largest first rounds of financing in some time.”
June 22, 2010
A four-week course to assist aspiring entrepreneurs with the business side of research discovery ends tonight with a lecture from UCSF alum and vice president of Genentech Partnering James Sabry.
June 11, 2010
UCSF’s Mission Bay campus has served as a catalyst for the booming biotechnology sector in San Francisco, according to a new economic impact report released on June 11. See complete story on the Economic Impact Report site.
June 10, 2010
UCSF is contributing to the economic vitality of San Francisco and the Bay Area, according to a new economic impact report to be released on June 11.
February 11, 2010
Researchers, who are interested in taking their research from the bench to the bedside, are encouraged to apply for a catalyst award by March 1.
January 21, 2010
UCSF is proceeding with the construction of the neurosciences building at Mission Bay, where some of the world’s best scientists and clinicians will collaborate to prevent and cure diseases of the brain.
January 06, 2010
QB3 researchers at the UCSF Sandler Center for Basic Research in Parasitic Diseases are preparing to apply for FDA approval to test an Investigational New Drug (IND) for Chagas disease, in what could become the first drug to emerge from UCSF without an industry partner.
November 04, 2009
Chancellor Sue Desmond-Hellmann stresses the importance of investing in science and education to recruit and retain “the best and the brightest” to keep California on the cutting-edge of innovation.